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Abstract. The discriminatory power of rapid eye movement (REM) density in 61 
outpatients with medical, neurologic, and psychiatric disorders and 8 noncase 
controls was assessed. REM density was significantly lower in a group of patients 
with medical-neurologic disease as compared with psychiatric and control subjects 
without evidence for such disease. Furthermore, low scores discriminated depres- 
sions occurring in the context of somatic disease when compared with those in the 
absence of such disease. The differences between groups were not accounted for by 
age or sex. The cutoff REM density score of 12.56, based on the 99% lower 
confidence limit of the noncase controls, provided the highest sensitivity (0.82) 
without loss of specificity (0.80). It was concluded that REM density may have 
merit as a general measure of diffuse central nervous system pathology, whether 
primary or secondary to widespread systemic disease. The findings of Kupfer’s 
group are upheld and extended to a broader medical and neuropsychiatric popula- 
tion than in the original Pittsburgh study. 
Key Words. REM density, sleep electroencephalogram, biological marker, neu- 
ropsychiatric disorders. 
Over the past several years new strategies have been developed for exploring the 
usefulness of biological tests for making psychiatric diagnoses (Akiskal and Webb, 
1978). Objective markers that appear ripe for clinical application include the dexa- 
methasone suppression test and various electroencephalographic (EEG) sleep 
parameters (Kupfer, 1976; Akiskal, 1980; Carroll et al., 1981). 
The search for EEG sleep correlates of psychiatric diagnostic categories has met 
with considerable success in the area of affective disorders (Kupfer and Foster, 1972; 
Kupfer et al., 1973; Foster et al., 1976; Kupfer, 1976; Kupferet al., 1976, 1978; Gillin et 
al., 1979; Kupfer et al., 1980a, 1980b). In a series of publications the Pittsburghgroup 
has shown that rapid eye movement (REM) latency and REM density distinguish 
primary from secondary depression. Thus, primary depressives have shorter REM 
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latency and higher REM density, while secondary depressives show less severe disrup- 
tion of sleep continuity and have a lower REM percentage. Furthermore, secondary 
depressives without medical disease have less sleep continuity disruption, higher REM 
percentage, and higher REM density than secondary depressives with medical disease 
(Kupfer and Heninger, 1972; Foster et al., 1976). Psychotic depressives tend to have 
shorter REM latency, more sleep continuity disturbance, and lower delta and REM 
percentages than their nonpsychotic counterparts (Kupfer et al., 1980~). The sleep of 
schizoaffectives more closely resembles that of psychotic depressives than of schizo- 
phrenics (Kupfer, 1976). 
In general, REM latency has received considerably more attention as a potential 
biological marker of primary, melancholic, and psychotic depression than REM 
density (Kupfer et al., 1978). In the present study, we examined REM density in 
medically, neurologically, and psychiatrically ill patients and in noncase controls. 
Following the lead of Kupfer’s group, we undertook to determine the usefulness of this 
measure for distinguishing these groups in a broader clinical population than in the 
original Pittsburgh study (Foster et al., 1976). 
Methods 
Subjects and Procedure. Sixty-one patients with at least 2 consecutive nights of sleep 
polysomnography were selected from clinical referrals to the Sleep Disorder Center. These 
patients all received the clinically standardized routine evaluation of our Center which includes: 
(1) being free of psychoactive drugs (including steroids) for at least 2-3 weeks before polysomno- 
graphy; (2) the Stanford Sleep Questionnaire and comprehensive sleep history; (3) neurologic 
and medical history and examination; (4) auditory evoked potentials; (5) a routine EEG to rule 
out seizure disorder; (6) formal psychiatric evaluation; (7) Beck Depression Inventory and 
Minnesota Multiphasic Personality Inventory; and (8) sleep polygraphic study consisting of 
continuous EEG, submental electromyogram, and two channels of electro-oculogram (EOG), 
scored according to the method of Rechtschaffen and Kales (1968). When necessary, further 
clinical or laboratory information was obtained from referring physicians’ records. Clinical 
information was abstracted “blind” to neurophysiologic status. 
Diagnostic Criteria. Psychiatric diagnoses (Table la), following the Washington University 
schema (Feighner et al., 1972) were based on data obtained in semistructured interviews. 
Primary affective disorder (n = 18) refers to depression which occurs in the absence of 
nonaffective psychiatric diagnoses; four had bipolar and the remainder unipolar depression. 
Secondary affective disorder (n = 9) refers to depressions associated with life-threatening or 
incapacitating somatic illnesses or superimposed on “nonorganic” psychiatric conditions that 
are considered validated by followup studies; these include anxiety (panic in DSM-III), phobic 
and obsessive-compulsive disorders, Briquet’s disorder, sociopathy, schizophrenia, anorexia 
nervosa, transsexualism, and (ego dystonic) homosexuality. One patient who satisifed the 
criteria for primary depression except for mood change was considered undiagnosed (masked) 
depression. The group of psychiatric disorders (other than primary affective disorders) 
included: 3 with anxiety disorder (panic disorder in DSM-III); 3 with Briquet’s disorder; 1 with 
agoraphobia; 1 with obsessive-compulsive disorder; and 17 character-disordered patients who 
failed to meet Washington University criteria for specified validated diagnoses, but met DSM- 
lII(American Psychiatric Association, 1980) criteria for one or more personality disorders. One 
patient categorized as an undiagnosed neurotic disorder had developed anxiety- 
hypochondriacal symptoms following a central nervous system (CNS) febrile illness of 
unknown etiology. 
Table lh lists the medical and neurologic conditions that were documented either by physical 
examination and/or laboratory findings or history. Ten patients had both psychiatric and 
medical-neurologic diagnoses. 
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Table 1. Frequencies of psychiatric diagnoses and 
medical-neurologic conditions 
a. Psychiatric diagnoses 
Primary affective disorder 
Secondary affective disorder 
Undiagnosed (masked) depression 














b. Neurologic and medical conditions 
Abnormal evoked potential study1 3 
Coronary artery disease 3 
Localized frontal brain atrophy 2 
Pellizius Merezbacher 2 
Hypertensive cardiovascular disease 2 
Hypertension 1 
Pituitary adenoma (operated) 1 
Encephalitis (history) 1 
Meningitis (history) 1 
Normal pressure hydrocephalus 1 
Multiple sclerosis 1 
Cerebrovascular accident (history) 1 
Undiagnosed CNS febrile illness (history) 1 
lschemic labyrinthitis 1 
Guillain-Barr& (historyi 1 
Polymyalgia rheumatica 1 
Diabetes mellitus 1 
Abnormal glucose tolerance test 1 
Chronic anemia 1 
Gastric carcinoma 1 
Emphysema 1 
Chronic diverticulitis 1 
1. Based primarily on prolonged (i.e., beyond 2 SD of laboratory norms) 
interpeak latencies of waves I, II, and V. 
Two patients with chronic (5-10years)“polydrug abuse” (including sedative-hypnotic drugs 
and alcohol) were not included in the overall analyses but considered separately in the discus- 
sion, because there was uncertainty as to whether they should be included in the psychiatric or 
medical-neurologic group. 
Eight noncase controls, without evidence of psychiatric and medical-neurologic illness, 
provided a comparison group. 
Hierarchical Categorization of Study Groups. For purposes of data analysis each patient 
was assigned to only one of the study groups (Table 2): group I, CNS disorders (including 
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abnormal evoked potential study); group II, medical illnesses excluding specific CNS disorders; 
group III, primary affective disorder with no evidence of medical-neurologic disorder; group 
IV, all other psychiatric disorders; and group V, noncase controls. Since selection criteria did 
not exclude patients with more than one condition, the following rule was adopted for assigning 
patients with multiple diagnoses to groups: patients were assigned to group I if there was 
evidence of CNS disease or an abnormal evoked potential study regardless of whether they had 
other medical or psychiatric illnesses; those with medical illness but without CNS conditions 
were assigned to group II regardless of the presence or absence of psychiatric diagnoses; patients 
assigned to group III had primary affective disorder and no diagnosed somatic or other 
psychiatric illness; patients assigned to group IV had psychiatric illnesses other than primary 
affective disorder. Thus groups I, II, and IV included several patients with more than one 
diagnosis, whereas group III included patients with only one diagnosis. Group V comprised 
eight noncase controls. By this method the 59 patients and eight controls were sorted into five 
groups with unequal n’s, 
Table 2. Hierarchical categorization of 67 subjects 
studied 
Groups and diagnostic combinations n 
Group I (n = 14) 
CNS condition only 
CNS and medical condition 
CNS and medical condition and primary 
affective disorder 
CNS condition and primary affective 
disorder 
CNS condition and other psychiatric 
disorder 
Group II (n = 8) 
Medical condition only 
Medical condition and other psychiatric 
disorder 
Group Ill (n = 18) 
Primary affective disorder only 
Group IV (n = 21) 
Other psychiatric disorder only 
Other psychiatric disorders and secondary 
depression 








REM Density Measurement. REM density data represent the mean of nonadaptation 
nights. REM periods are scored in l-minute epochs. The actual rapid eye movements are scored 
when they show amplitudes greater than 25 JAV. REM density represents the actual number of 
minutes of rapid eye movements that occur during a REM period. REM density values are 
calculated by the following formula: 
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total minutes of rapid eye movements 
x 100 
total minutes of REM sleep 
Statistical Analysis. An unweighted means analysis of variance for unequal n’s was per- 
formed on REM density measures for the five groups. Scheffe’s test of multiple comparisons 
was performed to assess differences of REM density means between group pairs and to assess 
the difference between combined groups I and II and combined groups III, IV, and V. An 
analysis of variance and Scheffe comparisons were used to test for age differences between 
groups, and a chi square was used to test for sex differences between groups (Winer, 1971). 
Pearson correlations were determined for age and REM density and for sex and REM density. 
The sensitivity and specificity of REM density for discriminating subjects with medical- 
neurologic illness (groups I and II) from subjects without medical-neurologic illness (groups III, 
IV, and V) were determined by deriving cutoff points from noncase control data. Three cutoffs 
were obtained by calculating the 95%, 99%, and 99.9% one-tailed confidence intervals (standard 
error of the mean times the respective Zscores for each confidence interval). The total sample of 
REM density scores was thus dichotomized (once for each confidence interval) into: (a) scores 
falling at or above the cutoff and (b) scores falling below the cutoff. Chi squares were performed 
for each data set generated by the three cutoffs. 
Results 
For the five groups under study chi square did not show significant sex-ratio differen- 
ces (Table 3). On the other hand, analysis of variance revealed that groups differed 
significantly with respect to age (p < 0.05). Scheffe comparisons indicated that the 
control group was significantly younger than groups I and II; furthermore group II 
was significantly older than group IV. 
Table 3. Age and sex distribution for subject groups 
Aae2 
Groups n M:F ratio1 
I 14 4:3 
II a 4:l 
III 16 5:li 
IV 21 8:13 
V 8 5:3 
l.$ = 6.102. df = 4, p = NS. 
2. ANOVA, F = 3.381, df = 4, 62, p < 0.05 
Significant Scheffe’comparisons (age): 
I vs. v, p < 0.05. 
II vs. IV, p < 0.05. 







Pearson correlations between age and REM density (I = 0.016) and sex and REM 
density (r = 0.164) did not indicate a statistically significant association. 
Table 4 summarizes the results of analysis of variance for REM density for all 
groups. The overall analysis was significant (p< 0.01). Scheffe comparisons indicated 
that group II differed significantly (p < 0.05) from groups III and IV and that the 
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combined groups (I and II) differed significantly from the combined groups (III, IV, 
and V) @ < 0.05). Further analyses (Table 5) revealed that depressed patients with 
medical-neurologic diagnoses had significantly lower REM density than depressed 
patients without medical-neurologic diagnoses @ < 0.01). 
Table 4. REM density comparisons between groups 
Groups 
I II III IV V 
n 14 8 16 21 8 
Mean 12.33 4.51 20.23 20.95 18.03 
SD 11.96 3.42 10.33 12.43 6.65 
ANOVA, F = 4.576, df = 4, 62, p < 0.01 
Significant Scheffk comparisons: 
II vs. Ill, p < 0.05. 
II vs. IV, p c 0.05. 
(I + II J vs. (Ill + IV + V), p < 0.05. 
Table 5. REM density comparison between 
depressed patients with neurologic or medical 
illness (D+) and those without evidence of 
neurologic or medical illness (D-) 
P+) (D-1 
n 6 21 
Mean 3.57 21.87 
SD 2.48 13.02 
ANOVA, F = 10.53, df = 2, 26, f~ < 0.01. 
To assess the diagnostic usefulness of REM density scores for discriminating 
medical-neurologic patients from those without such illnesses, a series of REM density 
“cutoff” points were derived based on the mean of the normal control group (XRD = 
18.03). Table 6 is based on the one-tailed confidence intervals (95% 99%,-99.9%) 
obtained by multiplying the standard error of the mean (2.35) of the noncase controls 
by the 2 scores for each of the intervals yielding the following cutoff values: 14.16; 
12.56; 10.77. Chi-square tables were developed for each of these values, and diagnostic 
sensitivities and specificities for each cutoff point were computed. Sensitivities ranged 
from 0.73 to 0.82, and specificities from 0.71 to 0.89. These figures indicated that 
regardless of the cutoff used, the majority of somatically ill subjects had “low” (i.e., 
below the cutoff) REM density, while most subjects without such illness had “normal” 
or “high” REM density (i.e., values above the cutoff). 
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Table 6. Diagnostic sensitivties and specificities for the 3 REM 
density cutoff scores for discriminating between subjects 
with somatic conditions (groups I + II) and those without 
such conditions (groups Ill + IV f V)l 
Cutoff 14.16 (95%) 12.56 (99O/o) 10.77 (99.9%) 
x1* 16.65 23.47 26.07 
Sensitivity 0.82 0.82 0.73 
Specificity 0.71 0.80 0.89 
l.df=l,p<O.Ol 
Discussion 
The results of the present study revealed a significant inverse relationship between 
phasic REM activity (REM density) and the presence of neurologic and/or medical 
illness. Thus a rank ordering of the mean REM densities for the groups yielded: II < I 
< V < III < IV (4.5 1<12.33 <18.03 <20.23 <20.95). The medical group significantly 
differed from the primary affective and other psychiatric groups. The difference 
between the medical and control groups approached but did not reach significance. 
The neurologic group did not differ significantly from any other group. However, 
when medical and neurologic groups were combined, they were significantly different 
from the combined psychiatric and control groups. Since the groups differed in age, it 
was necessary to examine the impact of age on REM density. Pearson correlation (r= 
0.016) for age and REM density suggested that in our sample very little of the REM 
density variance could be accounted for by age. Further, a Pearson correlation 
coefficient of 0.164 for REM density and sex indicated that REM density and sex were 
not strongly associated. 
The overall trend of the data was, therefore, for subjects with medical-neurologic 
illness to have lower REM density values than subjects without such illness (primary 
affectives, other psychiatric, and normal controls). This bimodal tendency was further 
supported when the REM density scores of patients with clinical depression were 
analyzed: depressed subjects with a medical-neurologic illness had low REM density 
(%RD = 3.57) compared to depressed subjects with no associated medical or neurologic 
illness (XRD = 21.87). 
The failure to find a statistically significant difference between the medical group 
and controls, and between the CNS group and psychiatric and control groups, 
requires further comment. An inspection of the individual scores of the medical group 
revealed that only one subject had a REM density value (11%) which fell within the 
99.9% one-tailed confidence intervals of the noncase control distribution. Thus, there 
was little overlap between the distribution of scores for the two groups, but because of 
large total variance of the sample, statistical analysis (Scheffk comparison) did not 
reach significance.1 Further, inspection of the individual scores for the CNS group 
reveals four scores which fell at or well above the upper 0.1% of the noncase control 
1. A f test, a less conservative test than the Scheffk comparison, was calculated comparing group II and 
group V. The difference was significant at the p < 0.005 level of confidence. 
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distribution (99.9% confidence interval, one-tailed-upper portion of the distribution = 
25.29). Statistically these scores were as “aberrant” as the “low” REM density scores. 
Whether “high” REM density is clinically significant is yet to be determined. Never- 
theless, it is interesting that in the CNS group there appear to be two distinct clusters of 
scores: (1) “low”: n = 10, %RD= 5.6, SD = 3.47; and (2) “high”: n = 4; %RD= 29.25, SD = 
7.14. The diagnoses of subjects with these high REM densities were: local frontal 
atrophy, REM density = 30; local frontal atrophy, REM density = 25; meningitis by 
history, REM density = 23; and multiple sclerosis, REM density = 39. Thus, the CNS 
group appears to be heterogeneous, and these few aberrantly high scores (in an 
otherwise low REM density CNS group) may explain why the CNS group was not 
significantly different from the psychiatric and control groups. Studies with larger 
sample size and a wide variety of CNS lesions are needed to determine whether this 
bimodality of scores for the CNS group is valid or artifactual; and to determine what 
type of CNS lesion is associated with a significant reduction in REM density. There is 
some evidence to suggest that the frontal cortex has an inhibitory effect on rapid eye 
movements, and the visual cortex is facilitatory (Appenzeller and Fischer, 1968). 
Accordingly, destructive lesions of the frontal cortex are expected to result in 
increased rapid eye movement. This hypothesis is consistent with the finding of 
increased REM density in our two patients with localized frontal atrophy. Our sample 
also included two patients with cerebellar disease. Sleep polygraphic studies of similar 
patients with olivopontocerebellar degeneration have shown decreased REM density 
and REM percent (Neil et al., 1980). Because cerebellar lesions by themselves do not 
affect sleep mechanisms, the changes in REM density in patients with cerebellar 
disease might reflect dysfunction in caudal pontine (including locus ceruleus) nuclei. 
In our series, several subjects with diagnosed systemic but without manifest (diag- 
nosable) CNS disease showed low REM density (< 10.77). These included three 
patients with coronary artery disease; one patient with hypertensive cardiovascular 
disease and an abnormal glucose tolerance test; one patient with chronic anemia; one 
patient with gastric carcinoma. None of these subjects had history or evidence of 
cerebrovascular abnormality, yet all had extremely low REM densities. The finding of 
low REM density in these patients may extend the range of pathology which is 
reflected in diminished phasic REM activity. In studies by the Pittsburgh group 
(Foster et al., 1976; Kupfer et al., 1980~) patients with diagnoses of cardiovascular 
disease were not specifically mentioned. 
The usefulness of REM density in differentiating patients with medical or neuro- 
logic illnesses from psychiatric patients without concomitant medical-neurologic 
illnesses and from normal controls was supported by chi-square tests using different 
cutoff points for “low” REM density derived from the noncase control subjects’ 
scores. For each of the cutoff values, low REM density was strongly correlated with 
the presence of medical-neurologic illness. As expected, the lowest cutoff point (10.77) 
yielded the highest sensitivity and the lowest specificity, while the reverse was true for 
the highest cutoff point (14.16). The 12.56 cutoff yielded high specificity (0.80) without 
loss of sensitivity (0.82). 
Our original sample included two patients (excluded from analyses) with a primary 
diagnosis of chronic (5 to 10 years) polydrug abuse, including sedative-hypnotics and 
ethanol; they had been free of these drugs for a l-month period before the sleep study. 
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These patients had low REM density values (4% and 2.7%). In the analyzed sample, 
patients with REM density in this low range invariably had a medical or CNS illness. 
This finding is consistent with other evidence linking chronic sedative-hypnotic and 
alcohol abuse to CNS dysfuncton (Ballenger and Post, 1978; Judd and Grant, 1978). 
The data from our outpatient sample support and extend the findings generated by 
Kupfer’s laboratory with regard to low REM density in secondary depressions in 
medically ill inpatients. It appears that low REM density is associated with a wide 
variety of somatic conditions regardless of the presence or absence of affective 
disorder. It would be premature to speculate about the precise neurophysiologic 
mechanisms responsible for low REM density. However, the available data suggest 
that disturbances which “diffusely” affect brain tissue may be more likely to result in 
low REM density than lesions with localized impact; caudal pontine lesions might be 
the exception to this generalization. It is possible that widespread systemic diseases 
may diffusely affect brain function in subtle ways (e.g., decreased REM density) which 
are not otherwise manifest in “gross” neurologic testing. Since the visual system is 
widely distributed in the brain, it is to be expected that a diverse and heterogeneous 
group of both CNS and systemic diseases (as well as pontine lesions with direct impact 
on eye movements) would affect phasic REM activity. Hence, low REM density may 
serve as a general indicator of diffuse CNS pathology of diverse origin whether 
endogenous, or exogenously produced. 
Work on a large sample is in progress in our laboratory to explore further the 
common somatic denominator of conditions associated with low REM density and 
the usefulness of this measure in the differential diagnosis of neuropsychiatric, 
medical-psychiatric, and “functional” psychiatric disorders. 
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